Home » Topics » Conferences

Conferences
RSS

ACAT inhibitor synthesized at Slovakofarma and presented at EFMC symposium

Sep. 21, 1998

International team reports discovery of novel immunostimulants

Sep. 21, 1998

Search for 5-HT2C ligands at Organon leads to the full agonist Org-38457

Sep. 18, 1998

Stilbene analogue of pranlukast is a potent LTD4 antagonist with improved pharmacokinetics

Sep. 18, 1998

RPR-132703: a second-generation PDE4 inhibitor from Rhone-Roulenc Rorer

Sep. 18, 1998

Selective and sensitive p38 MAP kinase inhibitor identified by SmithKline Beecham

Sep. 18, 1998

Astra describes SAR leading to antithrombotic agent with novel mechanism of action

Sep. 18, 1998

Pharmacological characterization of new Astra agent for airways diseases presented at EFMC

Sep. 18, 1998

New treatment for BPH discovered by Hungarian research team

Sep. 17, 1998

GW-273227, a sodium channel blocker for the treatment of pain

Sep. 17, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...